Scott Kathleen D. (CIK 1794284) reported 5 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-16). Recent activity: Sell DRMA (11 shares), Buy SPRY (12,500 shares), Sell SPRY (12,500 shares), Buy SPRY (50,000 shares), Sell SPRY (50,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-16 | Dermata Therapeutics, Inc. (DRMA) | Director | Sell | 11 | $13 |
| 2025-08-22 | ARS Pharmaceuticals, Inc. (SPRY) | Chief Financial Officer | Buy | 12,500 | $18,750 |
| 2025-08-22 | ARS Pharmaceuticals, Inc. (SPRY) | Chief Financial Officer | Sell | 12,500 | $187,500 |
| 2025-05-22 | ARS Pharmaceuticals, Inc. (SPRY) | Chief Financial Officer | Buy | 50,000 | $75,000 |
| 2025-05-22 | ARS Pharmaceuticals, Inc. (SPRY) | Chief Financial Officer | Sell | 50,000 | $705,000 |
Source: SEC Form 4 filings · as of 2026-06-16